The pathogenesis of TTP is based on unrestrained growth of microvascular platelet rich-thrombi due to the deficiency of plasma ADAMTS13 activity, the only biologic marker specific for TTP [1–3]. Here, ADAMTS13 is linked to thrombotic thrombocytopenic purpura.